4//SEC Filing
Shmagin Martin E 4
Accession 0001013762-09-000431
CIK 0000932352other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:28 PM ET
Size
7.7 KB
Accession
0001013762-09-000431
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-03-09$0.09/sh+1,000$90→ 3,131,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-13$0.09/sh+1,000$90→ 3,134,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-11$0.09/sh+2,000$180→ 3,133,073 total
Documents
Issuer
Urigen Pharmaceuticals, Inc.
CIK 0000932352
Entity typeother
Related Parties
1- filerCIK 0001407236
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 6:28 PM ET
- Size
- 7.7 KB